Annual EBITDA
-$12.46 M
-$708.00 K-6.02%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual EBITDA is -$12.46 million, with the most recent change of -$708.00 thousand (-6.02%) on December 31, 2023.
- During the last 3 years, NRBO annual EBITDA has risen by +$17.21 million (+57.99%).
- NRBO annual EBITDA is now -4585.71% below its all-time high of -$266.00 thousand, reached on December 31, 2014.
Performance
NRBO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.25 M
+$3.82 M+37.94%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly EBITDA is -$6.25 million, with the most recent change of +$3.82 million (+37.94%) on September 30, 2024.
- Over the past year, NRBO quarterly EBITDA has dropped by -$4.01 million (-178.33%).
- NRBO quarterly EBITDA is now -255.65% below its all-time high of $4.02 million, reached on December 31, 2018.
Performance
NRBO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$25.46 M
-$2.36 M-10.23%
September 30, 2024
Summary
- As of February 12, 2025, NRBO TTM EBITDA is -$25.46 million, with the most recent change of -$2.36 million (-10.23%) on September 30, 2024.
- Over the past year, NRBO TTM EBITDA has dropped by -$12.99 million (-104.24%).
- NRBO TTM EBITDA is now -1502.01% below its all-time high of -$1.59 million, reached on March 31, 2015.
Performance
NRBO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NRBO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.0% | -178.3% | -104.2% |
| 3 y3 years | +58.0% | -81.2% | +15.7% |
| 5 y5 years | +19.5% | -71.8% | -26.3% |
NRBO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +18.2% | -178.3% | +37.9% | -123.1% | at low |
| 5 y | 5-year | -6.0% | +58.0% | -178.3% | +67.9% | -123.1% | +15.7% |
| alltime | all time | -4585.7% | +62.4% | -255.7% | +67.9% | -1502.0% | +24.6% |
NeuroBo Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.25 M(-37.9%) | -$25.46 M(+10.2%) |
| Jun 2024 | - | -$10.08 M(+46.5%) | -$23.09 M(+37.3%) |
| Mar 2024 | - | -$6.88 M(+206.1%) | -$16.82 M(+35.0%) |
| Dec 2023 | -$12.46 M(+6.0%) | -$2.25 M(-42.3%) | -$12.46 M(-2.6%) |
| Sep 2023 | - | -$3.89 M(+2.3%) | -$12.79 M(+6.6%) |
| Jun 2023 | - | -$3.81 M(+51.1%) | -$12.00 M(+5.2%) |
| Mar 2023 | - | -$2.52 M(-2.3%) | -$11.41 M(-2.9%) |
| Dec 2022 | -$11.76 M(-22.8%) | -$2.58 M(-16.9%) | -$11.76 M(-14.4%) |
| Sep 2022 | - | -$3.10 M(-3.5%) | -$13.73 M(-2.5%) |
| Jun 2022 | - | -$3.21 M(+12.3%) | -$14.08 M(-4.7%) |
| Mar 2022 | - | -$2.86 M(-37.1%) | -$14.78 M(-3.0%) |
| Dec 2021 | -$15.24 M(-48.6%) | -$4.55 M(+31.9%) | -$15.24 M(-49.5%) |
| Sep 2021 | - | -$3.45 M(-11.8%) | -$30.19 M(+1.4%) |
| Jun 2021 | - | -$3.91 M(+18.0%) | -$29.78 M(+5.4%) |
| Mar 2021 | - | -$3.32 M(-83.0%) | -$28.25 M(-4.8%) |
| Dec 2020 | -$29.67 M(+47.2%) | -$19.50 M(+539.7%) | -$29.67 M(+32.8%) |
| Sep 2020 | - | -$3.05 M(+28.1%) | -$22.35 M(-2.6%) |
| Jun 2020 | - | -$2.38 M(-49.8%) | -$22.94 M(+2.2%) |
| Mar 2020 | - | -$4.74 M(-61.1%) | -$22.45 M(+11.3%) |
| Dec 2019 | -$20.16 M | -$12.18 M(+234.6%) | -$20.16 M(+409.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$3.64 M(+93.1%) | -$3.96 M(-36.4%) |
| Jun 2019 | - | -$1.89 M(-23.1%) | -$6.22 M(-42.7%) |
| Mar 2019 | - | -$2.45 M(-161.0%) | -$10.87 M(-29.8%) |
| Dec 2018 | -$15.49 M(-53.2%) | $4.02 M(-168.0%) | -$15.49 M(-40.6%) |
| Sep 2018 | - | -$5.91 M(-9.6%) | -$26.07 M(-9.2%) |
| Jun 2018 | - | -$6.53 M(-7.5%) | -$28.70 M(-12.2%) |
| Mar 2018 | - | -$7.06 M(+7.6%) | -$32.69 M(-1.3%) |
| Dec 2017 | -$33.12 M(+125.4%) | -$6.57 M(-23.1%) | -$33.12 M(-2.0%) |
| Sep 2017 | - | -$8.54 M(-18.8%) | -$33.78 M(+17.9%) |
| Jun 2017 | - | -$10.52 M(+40.1%) | -$28.65 M(+43.4%) |
| Mar 2017 | - | -$7.50 M(+3.8%) | -$19.97 M(+35.9%) |
| Dec 2016 | -$14.70 M(+105.0%) | -$7.23 M(+112.5%) | -$14.70 M(+47.3%) |
| Sep 2016 | - | -$3.40 M(+84.9%) | -$9.98 M(+11.6%) |
| Jun 2016 | - | -$1.84 M(-17.3%) | -$8.94 M(+2.6%) |
| Mar 2016 | - | -$2.23 M(-11.4%) | -$8.71 M(+7.9%) |
| Dec 2015 | -$7.17 M(+2594.7%) | -$2.51 M(+6.1%) | -$8.08 M(+45.1%) |
| Sep 2015 | - | -$2.37 M(+47.0%) | -$5.57 M(+74.0%) |
| Jun 2015 | - | -$1.61 M(+1.3%) | -$3.20 M(+101.3%) |
| Mar 2015 | - | -$1.59 M | -$1.59 M |
| Dec 2014 | -$266.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual EBITDA year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly EBITDA year-on-year change?
- What is NeuroBo Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM EBITDA year-on-year change?
What is NeuroBo Pharmaceuticals annual EBITDA?
The current annual EBITDA of NRBO is -$12.46 M
What is the all time high annual EBITDA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual EBITDA is -$266.00 K
What is NeuroBo Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, NRBO annual EBITDA has changed by -$708.00 K (-6.02%)
What is NeuroBo Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of NRBO is -$6.25 M
What is the all time high quarterly EBITDA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly EBITDA is $4.02 M
What is NeuroBo Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, NRBO quarterly EBITDA has changed by -$4.01 M (-178.33%)
What is NeuroBo Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of NRBO is -$25.46 M
What is the all time high TTM EBITDA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM EBITDA is -$1.59 M
What is NeuroBo Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, NRBO TTM EBITDA has changed by -$12.99 M (-104.24%)